ADAM TAYLOR: Open Payments
NPI 1376098335 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 20 payments from 12 companies in 2025. Trend: 2023 $211 · 2024 $216 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Novo Nordisk Inc | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| Resmed Corp | 1 | $23 |
| Radius Health, Inc. | 1 | $21 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
Products named: REXULTI, CAPLYTA, BREZTRI, CAPVAXIVE, AIRSENSE, Rybelsus, Tymlos, AIRSUPRA.
Industry payments across NE — which companies pay providers there.
